Showing posts with label Psychostimulant. Show all posts
Showing posts with label Psychostimulant. Show all posts
Saturday, April 27, 2019
Tuesday, April 9, 2019
Psychostimulant Use and Fatal Stroke in Young Adults
Be careful out there. Articles like these are why doctors first accuse young adults of drug use rather than testing for stroke.
Factors Associated With Misdiagnosis of Acute Stroke in Young Adults
Psychostimulant Use and Fatal Stroke in Young Adults
First published: 02 April 2019
Get access to the full version of this article.View access options below.
Abstract
Psychostimulant use is associated with increased stroke
risk. To determine the proportion of psychostimulant users among fatal
strokes in young adults (15–44 years), all cases were retrieved from the
National Coronial Information System (1/1/2009–31/12/2016). A total of
279 cases were identified: hemorrhagic (259), ischemic (8), thrombotic
(8), and mycotic (4). Fifty (17.9%) were identified as psychostimulant
users. Psychostimulants in blood were detected in 37/45 where toxicology
was available, predominantly methamphetamine (32/45). Hemorrhagic
strokes in the psychostimulant group were more likely to be
intraparenchymal (OR 2.33). Psychostimulant users were less likely to be
obese (OR 0.31), but more likely to have a history of tobacco use (OR
2.64). No psychostimulant user had a previous stroke history, was
gravid/postpartum, or diagnosed with cerebral vasculitis or
endocarditis. The work illustrates the substantial role of
psychostimulant use in fatal strokes among young adults. In cases of
hemorrhagic stroke among young adults, psychostimulant use should be
considered.
Subscribe to:
Posts (Atom)